Concepedia

Jarno Kivioja

JK

Statistics

Publications

5

Citations

155

H-Index

5

Active since

2013

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

Institute for Molecular Medicine Finland

University of Oulu

Oulu University Hospital

Jarno Kivioja is an author at Helsinki University Hospital specializing in medicine, macular disorders, and macular disease.

Publications per year

2013–2021

5

Publications

5

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia

Jarno Kivioja, Angeliki Thanasopoulou, Ashwini Kumar et al. · Leukemia · 2018 · 61 citations

Medicine, Oncology, Pharmacotherapy +10

INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Asta Hautamäki, Jarno Kivioja, Satu Vavuli et al. · Retina · 2013 · 34 citations

Medicine, Molecular Genetics, Ophthalmology +17

The genetic variant rs4073 A→T of the <i>Interleukin‐8</i> promoter region is associated with the earlier onset of exudative age‐related macular degeneration

Asta Hautamäki, Sanna Seitsonen, Juha M. Holopainen et al. · Acta Ophthalmologica · 2015 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

The IL-8, VEGF, and CFH Polymorphisms and Bevacizumab in Age-related Macular Degeneration

Asta Hautamäki, Jarno Kivioja, Sanna Seitsonen et al. · Ophthalmology · 2014 · 18 citations

Medicine, Genetics, Ophthalmology +14

FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML

Jarno Kivioja, Disha Malani, Ashwini Kumar et al. · Scientific Reports · 2021 · 14 citations · Full text

Medicine, Genetics, Oncology +17

1–5 of 5